Zoldem Use In Pregnancy & Lactation

Use in Pregnancy: Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Zolpidem tartrate should be used during pregnancy only if the potential benefit outweighs the potential risk to the fetus.
Studies in children to assess the effects of prenatal exposure to zolpidem tartrate have not been done; however, there have been case reports of severe neonatal respiratory depression when zolpidem tartrate was used at the end of pregnancy, particularly when taken with other CNS-depressants. Children born to mothers taking sedative-hypnotic drugs may be at risk for withdrawal symptoms during the postnatal period. Neonatal flaccidity has also been reported in infants born to mothers who received sedative-hypnotic drugs during pregnancy.
Labor and delivery/Use in Lactation: There is no established use of zolpidem tartrate in labor and delivery.
Small quantities of zolpidem tartrate appear in breast milk. The use of zolpidem tartrate in breastfeeding mothers is therefore not recommended.